- home
- about us
- Investment Approach
- Client Service Approach
- Market Analysis Summary
- Mission Statement
- Value Proposition
- Team Biographies
- Firm ADV PDFs
- Form CRS
- Firm Brochure-Part 2A of Form ADV
- Brochure Supplement Amit Stavinsky
- Brochure Supplement Frank Parks
- Brochure Supplement Dominick Savo
- Brochure Supplement Richard Mason
- Brochure Supplement Joe Estes
- Brochure Supplement Jonathan Ezra
- Statement Of Financial Strength
- Job Opportunities
- Letter to Clients
- member log-in
- contact us
Latest News about TSHA
Recent news which mentions TSHA
Stocks That Hit 52-Week Lows On Friday
April 29, 2022
From Benzinga
Stocks That Hit 52-Week Lows On Tuesday
April 26, 2022
From Benzinga
10 Biggest Price Target Changes For Friday
April 01, 2022
From Benzinga
Tickers
TSHA
From Motley Fool
The Daily Biotech Pulse: Amylyx Announces Negative Adcom Vote, Clovis Jumps On Ovarian Cancer Data, Masimo Warns Of Q1 Shortfall
March 31, 2022
From Benzinga
Earnings Scheduled For March 31, 2022
March 31, 2022
From Benzinga
From Benzinga
From Benzinga
Taysha Gene Therapies Earnings Conference Call Is Coming Up, Here's What You Need To Know
March 25, 2022
Tickers
TSHA
From Benzinga
Stocks That Hit 52-Week Lows On Tuesday
March 15, 2022
From Benzinga
Stocks That Hit 52-Week Lows On Monday
March 14, 2022
From Benzinga
From Benzinga
Stocks That Hit 52-Week Lows On Tuesday
March 08, 2022
From Benzinga
From Benzinga
Stocks That Hit 52-Week Lows On Tuesday
February 22, 2022
From Benzinga
Two Insider Moonshots Rising on Sudden Buying
February 10, 2022
From InvestorPlace
Executives Buy Around $62M Of 3 Stocks
February 07, 2022
From Benzinga
Taysha Reports Efficacy, Safety Data From High Dose Cohort For Neurological Disorder Gene Therapy Trial
January 31, 2022
Tickers
TSHA
From Benzinga
12 Health Care Stocks Moving In Thursday's After-Market Session
January 20, 2022
From Benzinga
Stocks That Hit 52-Week Lows On Wednesday
January 19, 2022
From Benzinga
Stocks That Hit 52-Week Lows On Thursday
January 06, 2022
From Benzinga
Stocks Hitting New 52-Week Lows Today
January 03, 2022
From Benzinga
The Week Ahead In Biotech (Dec.26-Jan. 1): Xeris FDA Decision, Pending Clinical Readouts In Focus In Final Week Of Year
December 26, 2021
From Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For December 16, 2021
December 16, 2021
From Benzinga
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.